Plain-English translation of NCT06803784 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Parkinson Disease research guide →This research study is looking for specific protein patterns in blood and spinal fluid that could serve as early warning signs of neurodegenerative diseases like Parkinson's, Alzheimer's, ALS, and frontotemporal dementia. Researchers hope to develop simple blood tests based on these protein markers that could help doctors diagnose these conditions earlier and better predict how the disease might progress. By studying these proteins, they may also discover new targets for future treatments.
Currently, diagnosing these nerve diseases often requires expensive brain scans or takes many years of watching symptoms develop. This research aims to find blood-based markers that could catch these diseases much earlier—potentially before major symptoms appear—which could make treatment more effective and help doctors personalize care for each patient.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be asked to donate blood samples and possibly spinal fluid samples at one or more visits to a research center. Researchers will also review your medical history and genetic information. Some participants may also have their cells studied in the laboratory to understand how these proteins behave. The study is observational, meaning you won't receive any new medication or treatment as part of the research—researchers are simply collecting samples and information to identify disease markers.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy